£172.19

It has never been this cheap. We have no record of a lower price.

£172 today · cheaper than every other day in the last 3 months

Elsevier Dopamine (Volume 211) (Progress in Brain Research, Volume 211)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 32 days · 32 data points (no recent data)

Historical
Generating forecast…
£175.00 £171.91 £172.58 £173.26 £173.93 £174.61 £175.28 25 July 2026 01 August 2026 09 August 2026 17 August 2026 25 August 2026
View at Amazon ↗

Price data last checked 59 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 32 days • 2 price levels

Days at Price
Current Price
1 day · current 31 days 0 8 16 23 31 £172 £175 Days at Price

Price Analysis

Most common price: £175 (31 days, 96.9%)

Price range: £172 - £175

Price levels: 2 different prices over 32 days

Description

Progress in Brain Research is a well-established international series examining major areas of basic and clinical research within neuroscience, as well as emerging and promising subfields. This volume, concentrates on state-of-the-art of dopamine research: from basic science to clinical applications. It covers topics including thalamostriatal synapses as a substrate for dopamine action; the multilingual nature of dopamine neurons; ethanol-mechanisms along the mesolimbic dopamine system, and much more.Progress in Brain Research is the most acclaimed and accomplished series in neuroscience, firmly established as an extensive documentation of the advances in contemporary brain research. The volumes, some of which are derived from important international symposia, contain authoritative reviews and original articles by invited specialists. The rigorous editing of the volumes assures that they will appeal to all laboratory and clinical brain research workers in the various disciplines: neuroanatomy, neurophysiology, neuropharmacology, neuroendocrinology, neuropathology, basic neurology, biological psychiatry, and the behavioral sciences. The most acclaimed and accomplished series in neuroscience This volume looks at dopamine research in the light of the newest scholarly discoveries and insights

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
28 June 2014
Listed Since
22 March 2014

Barcode

No barcode data available

Similar Products You Might Like

Dopamine in the CNS: Pt. 1 (Handbook of Experimental Pharmacology)
97% match

Dopamine in the CNS: Pt. 1 (Handbook of Experimental Pharmacology)

Springer

£91.49 27 Sep 2026
Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years Of Research: 60 (Current Topics in Behavioral Neurosciences, 60)
97% match

Therapeutic Applications of Dopamine D3 Receptor Function: New Insight After 30 Years Of Research: 60 (Current Topics in Behavioral Neurosciences, 60)

Springer

£83.07 30 Sep 2026
Dopamine Receptor Technologies: 96 (Neuromethods, 96)
97% match

Dopamine Receptor Technologies: 96 (Neuromethods, 96)

Humana

£79.93 01 Oct 2026
Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172
97% match

Serotonin-Dopamine Interaction: Experimental Evidence and Therapeutic Relevance (Progress in Brain Research): 172

Elsevier

£182.59 25 Sep 2026
New Developments in Dopamine Research
97% match

New Developments in Dopamine Research

£104.99 13 Sep 2026
Dopamine (Volume 21) (Handbook of Chemical Neuroanatomy, Volume 21)
97% match

Dopamine (Volume 21) (Handbook of Chemical Neuroanatomy, Volume 21)

Elsevier

£280.00 23 Aug 2026
Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)
97% match

Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)

Springer

£68.20 19 Sep 2026
Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)
97% match

Das dopaminerge Verstärkungssystem: Funktion, Interaktion mit anderen Neurotransmittersystemen und psychopathologische Korrelate: 100 (Monographien aus dem Gesamtgebiete der Psychiatrie, 100)

Springer

£54.71 19 Sep 2026
International Review of Neurobiology: Vol 54: Volume 54
96% match

International Review of Neurobiology: Vol 54: Volume 54

Elsevier

£45.81 08 Sep 2026
Neurobiology of DOPA as a Neurotransmitter
96% match

Neurobiology of DOPA as a Neurotransmitter

CRC Press

£260.00 27 Aug 2026
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
96% match

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Humana

£80.67 21 Sep 2026
Dopamine - Glutamate Interactions in the Basal Ganglia: 49 (Frontiers in Neuroscience)
96% match

Dopamine - Glutamate Interactions in the Basal Ganglia: 49 (Frontiers in Neuroscience)

CRC Press

£136.67 23 Sep 2026
Greenfinch Dopamine Home - Bold Interior Design Guide
96% match

Greenfinch Dopamine Home - Bold Interior Design Guide

Greenfinch

£17.71 26 Sep 2026
5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part B (Volume 261) (Progress in Brain Research, Volume 261)
96% match

5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance Part B (Volume 261) (Progress in Brain Research, Volume 261)

Elsevier

£167.59 05 Sep 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
96% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£104.34 17 Sep 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
96% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£79.26 11 Sep 2026
Chemical Biology of Neurodegeneration: Molecular Approach
96% match

Chemical Biology of Neurodegeneration: Molecular Approach

Wiley

£104.00 16 Sep 2026
Dopaminergic Neuron Transplantation in the Weaver Mouse Model of Parkinson’s Disease: 517 (Advances in Experimental Medicine and Biology, 517)
96% match

Dopaminergic Neuron Transplantation in the Weaver Mouse Model of Parkinson’s Disease: 517 (Advances in Experimental Medicine and Biology, 517)

Springer

£58.69 24 Sep 2026
Designer Receptors Exclusively Activated by Designer Drugs: 108 (Neuromethods, 108)
95% match

Designer Receptors Exclusively Activated by Designer Drugs: 108 (Neuromethods, 108)

Humana

£54.48 18 Sep 2026
Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)
95% match

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Springer

£128.31 27 Aug 2026
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)
95% match

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Elsevier

£129.00 01 Oct 2026
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
95% match

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Humana

£141.67 24 Sep 2026
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
95% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£81.06 26 Sep 2026
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
95% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£104.34 17 Sep 2026